Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Debt / NOTE 2.750%10/0
-
Market price (% of par)
-
220.13%
-
Total 13F principal
-
$202,102,000
-
Principal change
-
+$4,452,000
-
Total reported market value
-
$445,749,000
-
Number of holders
-
18
-
Value change
-
+$4,537,234
-
Number of buys
-
9
-
Number of sells
-
8
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 as of Q2 2014
As of 30 Jun 2014,
ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$202,102,000
in principal (par value) of the bond.
The largest 10 bondholders included
Fore Research & Management, LP, Citadel Advisors LLC, WOLVERINE ASSET MANAGEMENT LLC, WHITEBOX ADVISORS LLC, LORD, ABBETT & CO. LLC, TENOR CAPITAL MANAGEMENT Co., L.P., DEUTSCHE BANK AG\, CAPSTONE INVESTMENT ADVISORS, LLC, FMR LLC, and GUARDIAN LIFE INSURANCE CO OF AMERICA.
This page lists
18
institutional bondholders reporting positions
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.